AAAAAA
Results:
1-9
|
Results: 9
Authors:
Segall, GM
Citation: Gm. Segall, FDG PET imaging in patients with lymphoma: A clinical perspective - Invited commentary, J NUCL MED, 42(4), 2001, pp. 609-610
Authors:
Mcdougall, IR
Davidson, J
Segall, GM
Citation: Ir. Mcdougall et al., Positron emission tomography of the thyroid, with an emphasis on thyroid cancer, NUCL MED C, 22(5), 2001, pp. 485-492
Authors:
Liu, IJ
Zafar, MB
Lai, YH
Segall, GM
Terris, MK
Citation: Ij. Liu et al., Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer, UROLOGY, 57(1), 2001, pp. 108-111
Authors:
Jadvar, H
Johnson, DL
Segall, GM
Citation: H. Jadvar et al., The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma, CLIN NUCL M, 25(1), 2000, pp. 48-51
Authors:
Langleben, DD
Segall, GM
Citation: Dd. Langleben et Gm. Segall, PET in differentiation of recurrent brain tumor from radiation injury, J NUCL MED, 41(11), 2000, pp. 1861-1867
Authors:
Jadvar, H
Schambye, RB
Segall, GM
Citation: H. Jadvar et al., Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose, CLIN NUCL M, 24(12), 1999, pp. 965-967
Authors:
Jadvar, H
Strauss, HW
Segall, GM
Citation: H. Jadvar et al., SPECT and PET in the evaluation of coronary artery disease, RADIOGRAPHI, 19(4), 1999, pp. 915-926
Authors:
Hays, MT
Segall, GM
Citation: Mt. Hays et Gm. Segall, A mathematical model for the distribution of fluorodeoxyglucose in humans, J NUCL MED, 40(8), 1999, pp. 1358-1366
Authors:
Hanasono, MM
Kunda, LD
Segall, GM
Ku, GH
Terris, DJ
Citation: Mm. Hanasono et al., Uses and limitations of FDG positron emission tomography in patients with head and neck cancer, LARYNGOSCOP, 109(6), 1999, pp. 880-885
Risultati:
1-9
|